OPKO Health - Stock

OPKO Health Equity 2024

OPKO Health Equity

1.39 B USD

Ticker

OPK

ISIN

US68375N1037

WKN

A0MUUJ

In 2024, OPKO Health's equity was 1.39 B USD, a -11.04% increase from the 1.56 B USD equity in the previous year.

OPKO Health Aktienanalyse

What does OPKO Health do?

OPKO Health Inc is an American company specializing in diagnostics, biopharmaceuticals, and pharmaceutical products. It was founded in 1991 by Dr. Phillip Frost, who still serves as CEO. The company is headquartered in Miami, Florida, and employs around 6,000 people worldwide. In recent years, OPKO Health Inc has undergone strong expansion, particularly through several acquisitions of other companies. These include Bio-Reference Laboratories, Inc., a leading provider of diagnostic services, and EirGen Pharma, a European company specializing in the production of high-quality pharmaceuticals. The business model of OPKO Health Inc is based on the development and marketing of products and services in the field of diagnostics and medical research. The company operates numerous state-of-the-art laboratories worldwide, which conduct diagnostic tests, genetic analyses, and medical research. OPKO Health Inc offers a wide range of products and services distributed across multiple business areas. One important area is the diagnostics division, which offers a wide range of tests and services, including cancer diagnostics, blood tests, genetic analyses, and clinical trials. Another important business area of OPKO Health Inc is the biopharmaceutical division, which focuses on the development and marketing of innovative therapies and medical products. The company develops medications against cancer and other diseases, as well as vaccines and immunological therapies. A third important business area of OPKO Health Inc is the pharmaceutical products division, which specializes in the production and distribution of pharmaceutical products and generic medications. The company has a broad portfolio of products, ranging from over-the-counter painkillers to medications for rare diseases. One of OPKO Health Inc's key products is the 4Kscore test, a blood test for diagnosing prostate cancer. This test is approved in the US and Europe and has a high accuracy rate in detecting aggressive forms of cancer. Another important product of the company is Rayaldee-Tabs, an innovative vitamin D medication used for the treatment of patients with chronic kidney disease (CKD). The medication has shown high efficacy in clinical studies and is currently approved in the US and Europe. OPKO Health Inc has become a significant player in the field of medical research and diagnostics through strong expansion and numerous acquisitions in recent years. The company focuses on high quality and innovative technologies to best support its customers worldwide. OPKO Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing OPKO Health's Equity

OPKO Health's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding OPKO Health's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating OPKO Health's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

OPKO Health's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in OPKO Health’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about OPKO Health Stock

What is the equity of OPKO Health this year?

OPKO Health has equity of 1.39 B USD this year.

What was the equity of OPKO Health compared to the previous year?

The equity of OPKO Health has increased/decreased by -11.04% decreased compared to the previous year.

What impact does a high equity have on investors of OPKO Health?

A high equity is advantageous for investors of OPKO Health as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of OPKO Health?

A low equity can be a risk for investors of OPKO Health, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of OPKO Health affect the company?

An increase in equity of OPKO Health can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of OPKO Health affect the company?

A reduction in equity of OPKO Health can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of OPKO Health?

Some factors that can affect the equity of OPKO Health include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of OPKO Health so important for investors?

The equity of OPKO Health is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can OPKO Health take to change the equity?

To change equity, OPKO Health can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does OPKO Health pay?

Over the past 12 months, OPKO Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OPKO Health is expected to pay a dividend of 0 USD.

What is the dividend yield of OPKO Health?

The current dividend yield of OPKO Health is .

When does OPKO Health pay dividends?

OPKO Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OPKO Health?

OPKO Health paid dividends every year for the past 0 years.

What is the dividend of OPKO Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OPKO Health located?

OPKO Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von OPKO Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OPKO Health from 6/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did OPKO Health pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of OPKO Health in the year 2023?

In the year 2023, OPKO Health distributed 0 USD as dividends.

In which currency does OPKO Health pay out the dividend?

The dividends of OPKO Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The OPKO Health stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von OPKO Health

Our stock analysis for OPKO Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OPKO Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.